These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15886075)

  • 1. A new anti-obesity drug treatment: first clinical evidence that, antagonising glutamate-gated Ca2+ ion channels with memantine normalises binge-eating disorders.
    Hermanussen M; Tresguerres JA
    Econ Hum Biol; 2005 Jul; 3(2):329-37. PubMed ID: 15886075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS; Lipton SA
    J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of memantine.
    Johnson JW; Kotermanski SE
    Curr Opin Pharmacol; 2006 Feb; 6(1):61-7. PubMed ID: 16368266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity.
    Volbracht C; van Beek J; Zhu C; Blomgren K; Leist M
    Eur J Neurosci; 2006 May; 23(10):2611-22. PubMed ID: 16817864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia].
    Tanović A; Alfaro V
    Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors.
    Gilling KE; Jatzke C; Hechenberger M; Parsons CG
    Neuropharmacology; 2009 Apr; 56(5):866-75. PubMed ID: 19371579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine.
    Peeters M; Gunthorpe MJ; Strijbos PJ; Goldsmith P; Upton N; James MF
    J Pharmacol Exp Ther; 2007 May; 321(2):564-72. PubMed ID: 17267580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
    Wenk GL
    J Clin Psychiatry; 2006; 67 Suppl 3():3-7; quiz 23. PubMed ID: 16649845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-D-aspartate-gated channels.
    Chen HS; Lipton SA
    J Pharmacol Exp Ther; 2005 Sep; 314(3):961-71. PubMed ID: 15901795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ca2+ inhibits the association of memantine with N-methyl-D-aspartate (NMDA) receptor-gated ion channels.
    Fujimoto M; Iida H; Homma T; Kimura I; Mori M; Hamana H
    Biol Pharm Bull; 2008 Sep; 31(9):1813-5. PubMed ID: 18758084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memantine as an example of a fast, voltage-dependent, open channel N-methyl-D-aspartate receptor blocker.
    Parsons CG; Gilling K
    Methods Mol Biol; 2007; 403():15-36. PubMed ID: 18827985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of glutamate-related drugs on marble-burying behavior in mice: implications for obsessive-compulsive disorder.
    Egashira N; Okuno R; Harada S; Matsushita M; Mishima K; Iwasaki K; Nishimura R; Oishi R; Fujiwara M
    Eur J Pharmacol; 2008 May; 586(1-3):164-70. PubMed ID: 18423440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors in the cardiovascular effects of L-glutamate microinjection into the hypothalamic paraventricular nucleus of unanesthetized rats.
    Busnardo C; Tavares RF; Corrêa FM
    J Neurosci Res; 2009 Jul; 87(9):2066-77. PubMed ID: 19229989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond.
    Lipton SA
    Nat Rev Drug Discov; 2006 Feb; 5(2):160-70. PubMed ID: 16424917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMDA channel blockers: memantine and amino-aklylcyclohexanes--in vivo characterization.
    Danysz W; Parsons CG; Quack G
    Amino Acids; 2000; 19(1):167-72. PubMed ID: 11026485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat.
    Rosi S; Vazdarjanova A; Ramirez-Amaya V; Worley PF; Barnes CA; Wenk GL
    Neuroscience; 2006 Nov; 142(4):1303-15. PubMed ID: 16989956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamate-mediated neuroplasticity in an animal model of self-injurious behaviour.
    Muehlmann AM; Devine DP
    Behav Brain Res; 2008 May; 189(1):32-40. PubMed ID: 18243356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bis(7)-tacrine prevents glutamate-induced excitotoxicity more potently than memantine by selectively inhibiting NMDA receptors.
    Liu YW; Li CY; Luo JL; Li WM; Fu HJ; Lao YZ; Liu LJ; Pang YP; Chang DC; Li ZW; Peoples RW; Ai YX; Han YF
    Biochem Biophys Res Commun; 2008 May; 369(4):1007-11. PubMed ID: 18328812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memantine, an NMDA antagonist, prevents the development of hyperthermia in an animal model for serotonin syndrome.
    Nisijima K; Shioda K; Yoshino T; Takano K; Kato S
    Pharmacopsychiatry; 2004 Mar; 37(2):57-62. PubMed ID: 15048612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization.
    David HN; Ansseau M; Lemaire M; Abraini JH
    Biol Psychiatry; 2006 Jul; 60(1):49-57. PubMed ID: 16427030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.